ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

Former Therapist: VA Is Hurting Mental Health Care for Combat Veterans at Its Vet Centers

A former VA therapist says productivity pressure on counselors who treat veterans for mental health issues like PTSD is hurting the quality of care.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression